Drug Patents owned by Swedish Orphan

1. Drug name - ORFADIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9301932 SWEDISH ORPHAN Liquid pharmaceutical composition comprising nitisinone Feb, 2033

(10 years from now)

Drugs and Companies using NITISINONE ingredient

Treatment: Treatment of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
4MG/ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.